{
    "organizations": [],
    "uuid": "a0eaea3a4fd8c41128bf87c602e1781cc8cb322a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-celyad-successfully-administers-cy/brief-celyad-successfully-administers-cyad-01-in-first-patients-in-shrink-and-link-trials-idUSFWN1S91G4",
    "ord_in_thread": 0,
    "title": "Celyad Successfully Administers CYAD-01 In First Patients In Shrink And Link Trials",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 3 (Reuters) - Celyad SA:\n* CELYAD SUCCESSFULLY ADMINISTERS CYAD-01 IN FIRST PATIENTS IN SHRINK AND LINK TRIALS Source text for Eikon: (Gdynia Newsroom)\nOur ",
    "published": "2018-05-03T14:09:00.000+03:00",
    "crawled": "2018-05-04T17:11:28.042+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "celyad",
        "sa",
        "celyad",
        "successfully",
        "administers",
        "first",
        "patient",
        "shrink",
        "link",
        "trial",
        "source",
        "text",
        "eikon",
        "gdynia",
        "newsroom"
    ]
}